Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Sunshine Biopharma Inc SBFM

Healthcare Biotechnology
Sunshine Biopharma, Inc. is a Canada-based pharmaceutical company. The Company offers and researches life-saving medicines in a variety of therapeutic areas, including oncology and antivirals. The Company has 27 additional generic prescription drugs. In addition, the Company is engaged in the development of various proprietary drugs, including Adva-27a, K1.1 mRNA and SBFM-PL4. Adva-27a is a... see more

Recent & Breaking News (NDAQ:SBFM)

Sunshine Biopharma Launches a New Generic Prescription Drug

Accesswire 2 days ago

Sunshine Biopharma Reports 2024 Third Quarter Results: Year-To-Date Revenues Up 54%

Accesswire November 6, 2024

Sunshine Biopharma Launches Two New Generic Prescription Drugs

Accesswire September 26, 2024

Sunshine Biopharma Announces Publication of Significant Coronavirus Research Results in the Journal of Medicinal Chemistry

Accesswire September 4, 2024

Sunshine Biopharma Has Launched Nine New Generic Prescription Drugs in 2024: Now Marketing Sixty-One Generic Drugs in Canada

Accesswire August 26, 2024

Sunshine Biopharma Reports 2024 Second Quarter Results: Second QTR Revenues up 67%, YTD Revenues up 61%

Accesswire August 19, 2024

Sunshine Biopharma Announces Reverse Stock Split

Accesswire August 6, 2024

Sunshine Biopharma Reports 2024 First Quarter Results: Revenues Up 54%

Accesswire May 21, 2024

Sunshine Biopharma's Nora Pharma Receives Health Canada Approval for Niopeg(R), a Biosimilar of Neulasta(R)

Accesswire April 19, 2024

Sunshine Biopharma Announces Reverse Stock Split

Accesswire April 12, 2024

Sunshine Biopharma Reports Operating Results for the Fiscal Year Ended December 31, 2023

Accesswire April 1, 2024

Sunshine Biopharma, Inc. Announces Closing of $10.0 Million Underwritten Public Offering

Accesswire February 15, 2024

Sunshine Biopharma, Inc. Announces Pricing of $10.0 Million Underwritten Public Offering

Accesswire February 13, 2024

Sunshine Biopharma Moves Principal Office to New York City

GlobeNewswire December 4, 2023

Sunshine Biopharma Reports 2023 Third Quarter Results: Revenues up Significantly Over Last Year Due to a Key Acquisition

Accesswire November 13, 2023

Sunshine Biopharma Reports 2023 Second Quarter Results: Revenues Up 3,600%

GlobeNewswire August 11, 2023

Aegis Capital Corp. Acted as Exclusive Placement Agent on a $5.0 Million Private Placement Priced At-the-Market for Sunshine Biopharma, Inc. (NASDAQ:SBFM)

Accesswire May 16, 2023

Sunshine Biopharma Announces Closing of $5.0 Million Private Placement Priced At-the-Market

GlobeNewswire May 16, 2023

Sunshine Biopharma Announces Pricing of $5.0 Million Private Placement Priced At-the-Market

GlobeNewswire May 12, 2023

Sunshine Biopharma Reports 2023 First Quarter Results: Revenues Up 2,100%

GlobeNewswire May 11, 2023